Canadian Cancer Trials Group Bulletins

General


Recent Publications

Booth CM, Ohorodnyk P, Zhu L, Tu D, Meyer RM. Randomised controlled trials in oncology closed early for benefit: Trends in methodology, results, and interpretation (ONLINE). Eur J Can 2011, DOI: 10.1016/j.ejca.2010.12.005

http://www.ejcancer.info/article/S0959-8049%2810%2901179-2/abstract

___________________________________


LY.9 (MINT 39045) - Randomised Intergroup Trial of First Line Treatment for Patients With Diffuse Large B-Cell Non-Hodgkins Lymphoma With a CHOP-Like Chemotherapy Regimen With or Without the Anti-CD20 Antibody Rituximab (IDEC-C2B8)

Rieger M, Ísterborg A, Pettengell R, White D, Gill D, Walewski J, Kuhnt E, Loeffler M, Pfreundschuh M, Ho AD, for the MabThera International Trial (MinT) Group. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol 22: 664-70, 2011.

http://annonc.oxfordjournals.org/content/22/3/664.abstract?etoc